NPI: 1083621130 · PLAINVIEW, NY 11803 · General Acute Care Hospital · NPI assigned 08/02/2006
Authorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | CUSACK, MICHELE (SENIOR VICE PRESIDENT & CFO) |
| NPI Enumeration Date | 08/02/2006 |
Other providers sharing the same authorized official: CUSACK, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,270 | $45K |
| 2019 | 7,954 | $410K |
| 2020 | 19,729 | $1.04M |
| 2021 | 28,150 | $1.40M |
| 2022 | 28,232 | $1.19M |
| 2023 | 32,499 | $1.33M |
| 2024 | 24,796 | $963K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 7,945 | 7,622 | $1.38M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 5,273 | 5,151 | $1.02M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,416 | 3,339 | $638K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,729 | 1,711 | $372K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 590 | 588 | $335K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,725 | 1,694 | $331K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,588 | 1,558 | $315K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,072 | 2,015 | $292K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,301 | 2,238 | $279K |
| 80053 | Comprehensive metabolic panel | 10,308 | 9,817 | $198K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 909 | 893 | $171K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 525 | 519 | $113K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 881 | 519 | $90K |
| 36415 | Collection of venous blood by venipuncture | 13,159 | 11,604 | $76K |
| C1889 | Implantable/insertable device, not otherwise classified | 204 | 198 | $66K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,746 | 4,571 | $62K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,933 | 1,907 | $54K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 891 | 798 | $49K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 290 | 289 | $48K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 287 | 281 | $40K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 58 | 57 | $31K |
| 86850 | 1,982 | 1,912 | $31K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,946 | 2,823 | $29K |
| 86900 | 1,990 | 1,920 | $29K | |
| 86901 | 1,990 | 1,920 | $27K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 5,601 | 5,313 | $21K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 99 | 99 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 469 | 439 | $17K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 26 | 26 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,831 | 4,624 | $17K |
| 84702 | 3,704 | 3,553 | $15K | |
| 0225U | 1,101 | 1,050 | $15K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 616 | 613 | $15K |
| 71045 | Radiologic examination, chest; single view | 2,330 | 2,256 | $14K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,236 | 1,209 | $14K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 1,328 | 1,300 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | 937 | 917 | $13K |
| 85027 | 4,344 | 4,144 | $10K | |
| 83880 | 448 | 439 | $10K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 527 | 513 | $10K |
| 87631 | 194 | 192 | $9K | |
| 88312 | 548 | 545 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 573 | 570 | $8K |
| J3490 | Unclassified drugs | 2,304 | 2,217 | $7K |
| 81025 | 2,116 | 2,049 | $7K | |
| 88304 | 184 | 181 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | 1,350 | 1,335 | $6K |
| 82962 | 1,877 | 1,077 | $6K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 756 | 689 | $6K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 29 | 29 | $5K |
| 85610 | 2,293 | 2,239 | $4K | |
| 85730 | 2,214 | 2,165 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,988 | 1,927 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 327 | 315 | $3K |
| 70498 | 12 | 12 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6,303 | 5,991 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 482 | 451 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,097 | 2,024 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 691 | 643 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,616 | 2,482 | $2K |
| 83690 | 3,356 | 3,217 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 208 | 187 | $1K |
| 81001 | 2,828 | 2,722 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 24 | 24 | $1K |
| 84484 | 2,727 | 2,534 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 125 | 124 | $920.62 |
| J2704 | Injection, propofol, 10 mg | 329 | 329 | $743.32 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 14 | 13 | $707.55 |
| 72125 | Computed tomography, cervical spine; without contrast material | 49 | 49 | $610.04 |
| 85379 | 1,228 | 1,204 | $587.88 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 31 | 31 | $362.72 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 319 | 313 | $312.46 |
| 83735 | 1,003 | 977 | $290.83 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 14 | 14 | $261.03 |
| 83605 | 979 | 940 | $253.84 | |
| 90715 | 12 | 12 | $243.60 | |
| 87486 | 34 | 34 | $237.51 | |
| 87581 | 34 | 34 | $237.51 | |
| 88313 | 382 | 380 | $216.98 | |
| J7050 | Infusion, normal saline solution, 250 cc | 17 | 17 | $209.64 |
| 81003 | 856 | 850 | $205.80 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 227 | 227 | $198.52 |
| 87040 | 442 | 431 | $180.84 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 43 | 43 | $180.37 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 225 | 225 | $151.31 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 116 | 115 | $140.31 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 53 | 53 | $117.98 |
| 73630 | 28 | 26 | $73.94 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 145 | 145 | $65.39 |
| 82553 | 150 | 148 | $54.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 33 | 32 | $52.10 |
| 84443 | Thyroid stimulating hormone (TSH) | 39 | 39 | $51.35 |
| C9113 | Injection, pantoprazole sodium, per vial | 13 | 12 | $33.28 |
| J0690 | Injection, cefazolin sodium, 500 mg | 13 | 12 | $21.70 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 17 | 17 | $20.94 |
| 82550 | 110 | 108 | $14.63 | |
| 87186 | 16 | 16 | $13.32 | |
| 87081 | 19 | 19 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 28 | 28 | $0.00 |
| 96376 | 14 | 14 | $0.00 | |
| 70496 | 12 | 12 | $0.00 | |
| 73610 | 29 | 28 | $0.00 |